| Literature DB >> 24778883 |
Chris R Kenyon1, Robert Colebunders2.
Abstract
Objective. To identify the risk factors for HCV infection within married couples in Egypt. Methods. In 2008 Egypt conducted its first nationally representative survey of HCV prevalence. 11126 of the 12780 individuals aged 15-59 year who were sampled agreed to participate and provided information via a questionnaire about demographic and behavioural characteristics and blood for HCV antibody and RNA analysis. We assessed the risk factors for HCV infection in a subsample of 5182 married individuals via multivariate logistic regression. Results. Overall HCV antibody prevalence in the married couples was 18.2% (95% CI, 16.8-19.6). HCV antibody prevalence was higher in the husbands (23.7%) than the wives (12.1%; P < 0.001). Having a spouse who was infected with HCV was an independent risk factor for HCV infection with odds ratios of 2.1 (95% CI, 1.6-2.9) and 2.2 (95% CI, 1.6-3.1) for women and men, respectively. Husbands whose wives had experienced female genital cutting (FGC) had a higher prevalence of HCV and this relationship was driven by a strong association in urban areas. Amongst the women there was no association between FGC and HCV overall but in urban areas only women who had experienced FGC were HCV infected. Conclusions. This study provides additional evidence of the importance of intrafamilial transmission of HCV in Egypt.Entities:
Year: 2014 PMID: 24778883 PMCID: PMC3980990 DOI: 10.1155/2014/164357
Source DB: PubMed Journal: Int J Hepatol
Figure 1The structure of the Egyptian DHS 2008 and the derivation of the married couples subsample. 16527 ever-married women aged 15–49 were sampled in the key population indicators (KPI) survey. In a subsample of households surveyed in the KPI, 6702 women and 6078 men aged 15–49 were sampled in the special health topics (SHT) component. 2591 wives (aged 15–49) and their 2591 husbands (aged 15–59) could be linked to generate the married couples subsample.
HCV seroprevalence and age-adjusted odds ratios for selected characteristics (Egyptian DHS 2008).
| Risk factors | Number of exposed (%)a | Number of HCV antibody positive (%)b | Age-adjusted OR (95% CI) |
|
|---|---|---|---|---|
| Place of residence | ||||
| Rural | 3234 (37.6) | 661 (20.4) | 2.4 (1.9–3.0) | <0.001 |
| Urban | 1948 (62.4) | 233 (12.0) | 1 | |
| Region | ||||
| Urban governorates | 610 (11.8) | 76 (12.6) | 1 | |
| Lower Egypt—urban | 554 (10.7) | 69 (12.3) | 1.0 (0.7–1.5) | 0.994 |
| Lower Egypt—rural | 1608 (31.0) | 364 (22.9) | 2.7 (1.9–3.8) | <0.001 |
| Upper Egypt—urban | 600 (11.6) | 79 (13.5) | 1.1 (0.7–1.7) | 0.778 |
| Upper Egypt—rural | 1524 (29.4) | 294 (20.1) | 2.1 (1.5–3.0) | <0.001 |
| Frontier governorates | 286 (5.5) | 12 (4.5) | 0.3 (0.2–0.6) | 0.001 |
| Gender | ||||
| Women | 2591 (50) | 300 (12.1) | 0.7 (0.6–0.9) | <0.001 |
| Men | 2591 (50) | 594 (23.7) | 1 | |
| Men's age (years) | ||||
| 15–20 | 9 (0.4) | 0 (0) | ||
| 21–30 | 524 (20.2) | 50 (9.5) | 1 | |
| 31–40 | 877 (33.9) | 117 (13.3) | 1.5 (1.0–2.1) | 0.034 |
| 41–49 | 827 (31.9) | 268 (32.4) | 4.5 (3.3–6.3) | 0.000 |
| 50–59 | 354 (13.7) | 159 (44.9) | 7.7 (5.4–11.1) | 0.000 |
| Women's age (years) | ||||
| 15–20 | 154 (5.9) | 5 (3.3) | 1 | |
| 21–30 | 1018 (39.3) | 60 (5.9) | 1.8 (0.7–4.7) | 0.188 |
| 31–40 | 860 (33.2) | 104 (12.1) | 4.1 (1.6–10.2) | 0.002 |
| 41–49 | 559 (21.6) | 131 (23.4) | 9.1 (3.6–22.7) | 0.000 |
| Educational attainment | ||||
| Secondary completed | 2424 (46.8) | 282 (14.3) | 0.7 (0.6–0.9) | 0.001 |
| Incomplete secondary or less | 1473 (28.4) | 282 (19.9) | 0.9 (0.7–1.1) | 0.219 |
| No education | 1285 (24.8) | 330 (23.5) | 1 | |
| Wealth index quintile | ||||
| Richest | 1010 (19.5) | 118 (12.1) | 0.4 (0.3–0.5) | <0.001 |
| Rich | 942 (18.2) | 112 (12.9) | 0.5 (0.4–0.7) | <0.001 |
| Middle | 1128 (21.7) | 225 (21.2) | 0.9 (0.7–1.2) | 0.413 |
| Poor | 1056 (20.4) | 220 (22.0) | 0.9 (0.7–1.2) | 0.600 |
| Poorest | 1046 (20.2) | 219 (22.8) | 1 | |
| Parenteral antischistosomiasis therapy | ||||
| No | 4582 (88.4) | 707 (16.5) | 1 | |
| Yes | 600 (11.6) | 187 (32.1) | 1.7 (1.4–2.2) | <0.001 |
| Women: reports FGCc | ||||
| No | 132 (5.1) | 4 (3.9) | 1 | |
| Yes | 2459 (94.9) | 296 (12.5) | 2.9 (0.8–10.1) | 0.096 |
| Men: his wife reports FGCd | ||||
| No | 132 (5.1) | 11 (8.3) | 1 | |
| Yes | 2459 (94.9) | 583 (23.7) | 3.1 (1.5–6.6) | 0.003 |
| FGC performed byg | ||||
| Doctor | 386 (15.7) | 21 (5.6) | 1 | |
| Nondoctor | 2073 (84.3) | 275 (13.7) | 1.4 (1.1–1.7) | 0.003 |
| Blood transfusion | ||||
| No | 4931 (95.3) | 832 (17.8) | 1 | |
| Yes | 244 (4.7) | 60 (26.9) | 1.3 (0.9–1.8) | 0.132 |
| Multiple injectionse | ||||
| No | 4301 (83.0) | 751 (18.4) | 1 | |
| Yes | 881 (17.0) | 143 (17.1) | 0.9 (0.7–1.1) | 0.312 |
| Dental treatmente | ||||
| No | 1829 (35.3) | 270 (15.3) | 1 | |
| Yes | 3353 (64.7) | 624 (19.6) | 1.1 (0.8–1.2) | 0.609 |
| Total number of childrenh | ||||
| 0–2 | 1098 (42.4) | 73 (6.9) | 1 | |
| 3–5 | 1162 (44.9) | 154 (14.1) | 1.2 (1.0–1.6) | 0.427 |
| ≥6 | 331 (12.8) | 73 (24.5) | 2.1 (1.0–2.5) | 0.035 |
| Partner is seropositive for HCV | ||||
| No | 4288 (82.8) | 608 (15.1) | 1 | |
| Yes | 894 (17.3) | 286 (32.6) | 2.1 (1.6–2.7) | <0.001 |
| Partner is HCV RNA positive | ||||
| No | 4569 (88.2) | 686 (15.9) | 1 | |
| Yes | 613 (11.8) | 208 (34.7) | 2.3 (1.7–2.9) | <0.001 |
| Wife is HCV RNA positive | ||||
| No | 2291 (88.4) | 451 (20.4) | 1 | |
| Yes | 300 (11.6) | 143 (47.4) | 2.6 (2.0–3.4) | <0.001 |
| Husband is HCV RNA positive | ||||
| No | 1997 (77.0) | 157 (8.3) | 1 | |
| Yes | 594 (22.9) | 143 (24.3) | 2.5 (1.9–3.3) | <0.001 |
| Another household member is seropositive for HCV | ||||
| No | 4760 (91.9) | 798 (17.7) | 1 | |
| Yes | 422 (8.1) | 96 (23.3) | 1.6 (1.2–2.1) | 0.004 |
| Another household member is HCV RNA positive | ||||
| No | 4896 (94.5) | 834 (17.9) | 1 | |
| Yes | 286 (5.5) | 60 (23.0) | 1.5 (1.1–2.1) | 0.015 |
| Length of marriage | ||||
| 0–10 years | 2430 (46.9) | 258 (8.2) | 1 | |
| 11–20 years | 1574 (30.4) | 339 (17.6) | 1.2 (1.0–1.5) | 0.051 |
| >20 years | 1178 (22.7) | 461 (29.8) | 1.4 (1.1–1.8) | 0.016 |
FGC: female genital cutting.
aUnweighted percentage.
bWeighted percentage.
cNumbers for this row are for women only.
dNumbers for this row are for men only.
eDefined as 2 or more injections reported in the preceding 6 months.
fEver received dental treatment of any sort.
gOf all women who report undergoing FGC
hThe total number of children that women report giving birth to.
Prevalence of HCV antibodies in 2591 husband-wife pairs, stratified by female genital cutting (FGC) status of the woman (Egyptian DHS 2008).
| Wife's HCV antibody status (%) | |||
|---|---|---|---|
| Negative | Positive | Totalb (%) | |
| Wife has undergone FGC | |||
| Husband HCV negative | 1721 | 155 | 1876 (76.3) |
| Husband HCV positive | 442 | 141 | 583 (23.7) |
| Totala (%) |
|
|
|
| Wife has not undergone FGC | |||
| Husband HCV negative | 119 | 2 | 121 (91.7) |
| Husband HCV positive | 9 | 2 | 11 (8.3) |
| Totala (%) |
|
|
|
aRow percentages.
bColumn percentages.
Factors associated with 5182 husbands and wives testing seropositive for hepatitis C in the 2008 Egyptian Demographic and Health Survey: multivariate logistic regression model results (odds ratios, 95% confidence intervals, and P values).
| Women | Men | Urban women | Urban men | Rural women | Rural men | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Odds ratio | 95% CI | P value | Odds ratio | 95% CI | P value | Odds ratio | 95% CI | P value | Odds ratio | 95% CI | P value | Odds ratio | 95% CI | P value | Odds ratio | 95% CI | P value | |
|
| 2546 | 2546 | 953 | 953 | 1593 | 1593 | ||||||||||||
| Wife had FGC | 2.0 | 0.7–5.1 | 0.166 | 2.1 | 1.1–3.9 | 0.026 | 4.0 | 0.5–31 | 0.188 | 3.0 | 1.1–7.9 | 0.025 | 0.9 | 0.3–2.5 | 0.85 | 1.4 | 0.6–3.3 | 0.458 |
| Spouse is HCV RNA positive | 2.1 | 1.6–2.9 | 0.000 | 2.2 | 1.6–3.1 | 0.000 | 2.4 | 1.3–4.4 | 0.005 | 2.5 | 1.2–5.1 | 0.015 | 2.0 | 1.4–2.8 | 0.000 | 2.2 | 1.5–3.2 | 0.000 |
| Wealth index quintile | ||||||||||||||||||
| Poorest | Ref | |||||||||||||||||
| Poor | 1.2 | 0.9–1.8 | 0.260 | 0.9 | 0.7–1.3 | 0.698 | 1.9 | 0.5–7.6 | 0.379 | 0.2 | 0.1–0.6 | 0.002 | 1.2 | 0.8–1.8 | 0.333 | 1.1 | 0.8–1.5 | 0.527 |
| Middle | 1.0 | 0.6–1.5 | 0.922 | 1.2 | 0.9–1.6 | 0.248 | 0.9 | 0.2–3.5 | 0.855 | 0.4 | 0.2–0.9 | 0.035 | 1.1 | 0.7–1.7 | 0.670 | 1.4 | 1.0–1.9 | 0.063 |
| Rich | 0.7 | 0.4–1.1 | 0.097 | 0.7 | 0.5–0.9 | 0.017 | 0.8 | 0.2–3.1 | 0.796 | 0.2 | 0.1–0.5 | 0.000 | 0.8 | 0.4–1.4 | 0.378 | 0.9 | 0.6–1.5 | 0.727 |
| Richest | 0.5 | 0.3–0.8 | 0.003 | 0.7 | 0.5–1.0 | 0.087 | 0.6 | 0.2–2.5 | 0.508 | 0.3 | 0.1–0.6 | 0.001 | 0.5 | 0.2–1.1 | 0.082 | 1.3 | 0.7–2.2 | 0.381 |
| Ageb | 1.1 | 1.0-1.1 | 0.000 | 1.1 | 1.0-1.1 | 0.000 | 1.1 | 1.1-1.2 | 0.000 | 1.1 | 1.0-1.1 | 0.000 | 1.1 | 1.0-1.1 | 0.000 | 1.1 | 1.0-1.1 | 0.000 |
| Blood transfusion | 1.9 | 1.1–3.5 | 0.028 | 1.1 | 0.7–1.7 | 0.604 | 1.2 | 0.4–3.3 | 0.789 | 1.4 | 0.8–2.7 | 0.273 | 2.3 | 1.1–4.7 | 0.025 | 0.9 | 0.6–1.6 | 0.820 |
| Parenteral antischistosomiasis therapy | 1.7 | 1.1–2.8 | 0.016 | 1.3 | 1.0–1.7 | 0.025 | 1.9 | 0.6–5.8 | 0.254 | 2.3 | 1.4–3.8 | 0.002 | 1.7 | 1.1–2.9 | 0.028 | 1.1 | 0.9–1.5 | 0.412 |
| Another household member is HCV RNA positive | 0.8 | 0.5–1.4 | 0.455 | 1.2 | 0.8–1.9 | 0.361 | 1.1 | 0.3–4.1 | 0.915 | 1.5 | 0.5–4.6 | 0.518 | 0.7 | 0.4–1.4 | 0.319 | 1.2 | 0.7–1.9 | 0.496 |
| Length of marriage | ||||||||||||||||||
| 0–10 years | Ref | |||||||||||||||||
| 11–20 years | 1.0 | 0.7–1.6 | 0.887 | 1.3 | 1.0–1.8 | 0.044 | 0.6 | 0.2–1.5 | 0.285 | 1.4 | 0.8–2.3 | 0.243 | 1.2 | 0.7–2.1 | 0.416 | 1.4 | 1.0-2.0 | 0.056 |
| >20 years | 1.0 | 0.5–1.9 | 0.941 | 1.6 | 1.1–2.4 | 0.019 | 0.6 | 0.2–1.9 | 0.355 | 1.5 | 0.7–3.0 | 0.264 | 1.2 | 0.6–2.6 | 0.601 | 1.7 | 1.0–2.8 | 0.036 |
| Local HCV prevalencec | 1.1 | 1.1-1.1 | 0.000 | 1.1 | 1.0-1.1 | 0.000 | 1.1 | 1.0–1.2 | 0.001 | 1.0 | 1.0-1.1 | 0.033 | 1.1 | 1.1-1.1 | 0.000 | 1.1 | 1.0-1.1 | 0.000 |
| Number of childrend | 1.0 | 0.9–1.1 | 0.674 | NA | 1.0 | 0.8–1.3 | 0.695 | NA | 1.0 | 0.9-1.0 | 0.347 | NA | ||||||
NA: not applicable.
aNot entered into model due to collinearity; all nonexcised women were HCV negative (see text).
bAge is defined continuously in years.
cLocal HCV prevalence is defined as the HCV prevalence in the surrounding governorate.
dThe total number of children that women report giving birth to, here defined continuously.